Basic Information
Dr. Jian Wu，born in 1967,Chief physician, Professor, Supervisor of Ph. D. Who is the assistant principal and chief of neurological department in Beijing Tsinghua Changgung Hosptial （BTCH）, the chief of Center for Beijing Stroke Quality Control and Reformation, the chief of Cerebrovascular Biology Laboratory affiliate to Beijing Institute for Brain Disorders. At the same time, he isn’t only one of the ten talents in Beijing Tens-Hundreds -Thousands talent project, but also the academic leader of Beijing 215 project.
Education Experience
1986~1991, Tongji Medical University（Tongji Medical College, Huazhong University of Science and Technology）,M.B.
1995~2012 , Capital Medical University, neurological major, Ph.D.&M.D.
2000~2003，the Jackson Laboratory （Maine，USA），Post-doctorate.
2003~2006，University of Memphis（Tennessee，USA），MHA.
Learning Pluralize
National committee of the Chinese Society of Neurology(CSN)， deputy director of the China Association of Gerontology and geriatrics specialized in cardiovascular and cerebrovascular disease. younger committee of the CSN，deputy director of the Youth Committee of the Stroke and Prevention Project Committee affiliate to the National Health and Family Planning Commission， member of the Stroke and Prevention Project Committee affiliate to National Health and Family Planning Commission，professional committee member and academic secretary of the CSN specialized in cerebrovascular disease，member of the New York Science Academy，professional member of the American Stroke Association(ASA)，member of the American Association of Neuroscience(AAN). The editorial board member of the Chinese Medical Journal(CMJ)，the Chinese Journal of Geriatric Heart Brain and Vessel Diseases，the Chinese Journal of Cerebrovascular Diseases，the Journal of International Neurology and Neurosurgery，and the International Journal of Cerebrovascular Diseases.
Main Research Direction, Research Contents and Results
Engaged in clinical neurology for over 20 years, has experienced the long-term experience of domestic and international, has a rich clinical experience and research skills, not only good at dealing with common diseases of the nervous system and more proficient in diagnosis and treatment of difficult diseases. Currently focused on diseases of the nervous system of clinical diagnosis and treatment, research and teaching work, focusing on cerebrovascular disease, headache, vertigo, cognitive and neurological genetic diseases epidemiology, genetics, etiology, pathogenesis, and new treatment methods and preventive measures of research, and to undertake more than ten of the subject of Eleventh Five Year, 12th Five Year Plan, China's natural project, in the nature of major projects, the U. S. National Institutes of Health (NIH), Beijing Municipal Science and Technology Commission of major projects, the Beijing Municipal Education Commission, organization department and Health Bureau, the SCI and core journal articles published more than 100 papers, as editor and deputy editor completed seven monographs.
Representative Paper
1.Qiang Huang ,Hai-qing Song ,Xun-ming Ji,Wei-yang Cheng,Juan Feng,Jian Wu* ,Qing-feng Ma .Generalization of the Right Acute Stroke Prevention Strategies in Reducing in-Hospital Delays Published: May 6, 2016. http://dx.doi.org/10.1371/journal.pone.0154972
2.Song Xiaowei. Xue Sufang. Zhao Jingyan. Wu Jian*. Screening for Fabry's disease in young patients with ischemic stroke in a Chinese population. Int J Neurosci 2016
3.Wu Jian*. Huang Qiang. Ma Qing-Feng. What Matters in the Results of Repeated Intravenous Thrombolysis for Recurrent Ischemic Stroke? Eur Neurol ;2016:75(3-4) : 150-154 .
4.Huang Q, Ma QF, Feng J, Cheng WY, Jia JP, Song HQ, Chang H, Wu J*. Factors Associated with In-Hospital Delay in Intravenous Thrombolysis for Acute Ischemic Stroke: Lessons from China. PLoS One. 2015 Nov 17;10(11):e0143145. doi:10.1371/journal.pone.0143145. eCollection 2015.
5.Gao P, Zhao Z, Wang D, Wu J, Cai Y, Li T, Wu W, Shi H, He W, Zhu F, Jiao L,Ling F. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China. Interv Neuroradiol. 2015 Apr;21(2):196-204. doi:10.1177/1591019915581778. Epub 2015 May 1.
6.Huang Q1, Ma Q, Jia J, Wu J*.Referral leads to prehospital delay of intravenous thrombolysis for acute ischemic stroke in Beijing. Int J Stroke 2015,10(7):80-81.
7.Jian Wu, Dorothy N. Kakoola, Nataliya I. Lenchik, Dominic M. Desiderio, Dna R. Marshall, Ivan C. Gerling. Molecular Phenotyping of Immune Cells from Young NOD Mice Reveals Abnormal Metabolic Pathways in the Early Induction Phase of Autoimmune Diabetes. PLOS ONE.2012;7(10): e46941.
8.Wu Jian, Jia Long-fei, Jia Jian-ping. Awareness of secondary stroke prevention guidelines among neurologists in China: a cross-sectional online survey. Chinese Medical Journal. 2012; 125(11):1867-70.
